title: Deficiency of nitric oxide synthase 2 results in increased neointima formation in a mouse model of vascular injury.
abstract: Restenosis frequently occurs after arterial interventions. The inducible form of nitric oxide synthase (NOS2) may both promote and inhibit neointima formation. This study investigated the role of NOS2 for neointima formation in a mouse model of carotid artery injury. The common carotid artery was ligated in anesthetized mice. Homozygous NOS2 knockout mice were compared with wild-type B6/129 mice or wild-type mice treated with the pharmacologic NOS2 inhibitor aminoguanidine given orally daily after ligation (n = 6-8 in each group). Vessels were harvested for quantification of lesion size 4 weeks later, or serially after ligation for tissue analysis. mRNA for NOS2 increased 1-4 days after ligation of the carotid artery. Cell proliferation could be visualized with an antibody against proliferating cell nuclear antigen. An intimal smooth muscle cell layer, confirmed by an alpha-actin antibody, was observed in the lumen 4 weeks after injury. Inhibition of NOS2 by either pharmacologic or genetic approaches tended to increase the area of intima formation (P = 0.13 or P < 0.05, respectively) and increased the intima/media ratio (P = 0.14 and P < 0.01, respectively). Inhibition of NOS2 by two different approaches increased neointima formation in a mouse model of mechanical vessel injury, indicating that the NOS2 expressed in the injured vessel wall is beneficial.
authors.affiliation: Crafoord Laboratory of Experimental Surgery/Department of Thoracic Surgery, Karolinska Hospital, Stockholm, Sweden.
authors.forename: Allan
authors.initials: A
authors.lastname: Sirsjö
authors.forename: Anders
authors.initials: A
authors.lastname: Löfving
authors.forename: Göran K
authors.initials: GK
authors.lastname: Hansson
authors.forename: Dick
authors.initials: D
authors.lastname: Wågsäter
authors.forename: Shinichi
authors.initials: S
authors.lastname: Tokuno
authors.forename: Guro
authors.initials: G
authors.lastname: Valen
mesh_terms: D000818:Animals; D002340:Carotid Artery Diseases / Q000201:enzymology / Q000473:pathology*; D017536:Carotid Artery, Common / Q000201:enzymology / Q000473:pathology*; D002455:Cell Division / Q000502:physiology; D005260:Female; D006146:Guanidines / Q000494:pharmacology; D006965:Hyperplasia; D007150:Immunohistochemistry; D051379:Mice; D018345:Mice, Knockout; D009131:Muscle, Smooth, Vascular / Q000201:enzymology / Q000473:pathology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000172:deficiency* / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017539:Tunica Intima / Q000473:pathology*
chemical_list: D006146:Guanidines; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; C004479:pimagedine